'Interim analysis shows 91.4% efficacy for the Russian Sputnik vaccine' bookmarked by ~hackernews

Interim analysis shows 91.4% efficacy for the Russian Sputnik vaccine

sputnikvaccine.com

The efficacy of the Sputnik V vaccine is 91.4%, based on the second interim analysis of data obtained 28 days after administering the first dose (7 days after the second dose). Calculation was based on the analysis of data on volunteers (n = 18,794) who received both the first and second doses of the Sputnik V vacci...
- Add
1

More like this (3)

Single Pfizer jab can reduce asymptomatic Covid infections by 75%

theguardian.com

Cambridge doctors record sharp fall in infections after 12 days in Covid test analysis on healthcare...
Cambridge doctors record sharp fall in infections after 12 days in Covid test analysis on healthcare workersCoronavirus – latest updatesSee all our coronavirus coverageA single dose of the Pfizer vaccine can reduce asymptomatic infections by 75%, according to research that suggests the jab could substantially curtail transmission of the disease.Doctors in Cambridge recorded the sharp fall in infections after 12 days of the first...

coronavirus health infectious diseases medical research pfizer
1
Had Covid? You May Need Only One Dose

marginalrevolution.com

The barriers are breaking. Step by step we move closer to First Doses First. New results...
The barriers are breaking. Step by step we move closer to First Doses First. New results from a small-scale study suggest that people who have had COVID have strong reactions to the first dose and may not need the second dose. NYTimes: Based on these results, the researchers say, people who have had Covid-19 may […] The post Had Covid? You May Need Only...

economics medicine science
1
Sputnik V vaccine peer reviewed with efficacy of 91.6%

sputnikvaccine.com

In an interim analysis of a Phase III clinical trial, Sputnik V showed strong efficacy, immunogenicity...
In an interim analysis of a Phase III clinical trial, Sputnik V showed strong efficacy, immunogenicity and safety results. Efficacy of Sputnik V against COVID-19 was reported at 91.6%. Analysis included data on 19,866 volunteers, who received both the first and second doses of the Sputnik V vaccine or placebo at the...
1